Pdt Partners, LLC Concert Pharmaceuticals, Inc. Transaction History

Pdt Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.77 - $5.24 $46,314 - $64,373	-12,285 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $59,705 - $160,564	12,285 New	12,285 $61,000
Q3 2018 Nov 14, 2018	SELL	$12.82 - $17.88 $211,530 - $295,020	-16,500 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$16.83 - $21.66 $1.94 Million - $2.5 Million	-115,287 Reduced 87.48%	16,500 $278,000
Q1 2018 May 15, 2018	SELL	$19.24 - $28.03 $229,263 - $334,005	-11,916 Reduced 8.29%	131,787 $3.02 Million
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $1.18 Million - $2.45 Million	84,310 Added 141.95%	143,703 $3.72 Million
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $826,156 - $909,306	59,393	59,393 $876,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.